Copyright
©The Author(s) 2022.
World J Clin Cases. Feb 16, 2022; 10(5): 1527-1535
Published online Feb 16, 2022. doi: 10.12998/wjcc.v10.i5.1527
Published online Feb 16, 2022. doi: 10.12998/wjcc.v10.i5.1527
Table 2 Comparison of serum glucagon-like peptide-1 and matrix Gla protein levels in the three groups of study participants (mean ± SD)
| Group | n | GLP-1 (pmol/L) | MGP (nmol/L) |
| Case group | 60 | 9.19 ± 1.10 | 7.88 ± 0.92 |
| Control group | 60 | 13.88 ± 1.65 | 9.77 ± 1.52 |
| Healthy group | 60 | 17.07 ± 2.48 | 10.79 ± 1.63 |
| F | 280.527 | 67.487 | |
| P value | 0.000 | 0.000 |
- Citation: Xie FF, Zhang YF, Hu YF, Xie YY, Wang XY, Wang SZ, Xie BQ. Significance of serum glucagon-like peptide-1 and matrix Gla protein levels in patients with diabetes and osteoporosis. World J Clin Cases 2022; 10(5): 1527-1535
- URL: https://www.wjgnet.com/2307-8960/full/v10/i5/1527.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i5.1527